* Orgenesis Inc ORGS.OQ reported a quarterly adjusted loss
of 5
cents per share for the quarter ended in September. The lone
analyst forecast for the quarter was for a loss of 2 cents per
share.
* Revenue fell 7.9% to $7.99 million from a year ago;
analysts
expected $7.30 million.
* Orgenesis Inc's reported EPS for the quarter was a loss
of 5
cents.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Orgenesis Inc shares had risen by 0.7% this quarter and
lost 50.3% so far this year.
* The company reported a quarterly loss of $1.36 million.
* Wall Street's median 12-month price target for Orgenesis
Inc is
$9.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated from Refinitiv data November
11 at 02:31 p.m. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2022 -0.02 -0.05 Missed
Jun. 30 2022 -0.02 -0.22 Missed
Mar. 31 2022 -0.04 -0.16 Missed
Dec. 31 2021 -0.06 -0.21 Missed